Definitive Contract W911NF21C0038
Award Date
4/7/21
Potential Completion Date
9/24/25
Potential Value
$8M
Funding Federal Agency
Research Development and Engineering Command
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Hybrid Plastics, Incorporated
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Hattiesburg, MS 39401, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase III Action
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a "Hemostatic Agent" under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to JSL Innovations LLC, a small business, for the development of an Automated Hemorrhage Control Device. The contract has a ceiling value of $218,930.00 and a period of performance ending on March 25, 2022. The award was made on May 28, 2021 under a Broad Agency Announcement that sought proposals for SBIR and Small Business Technology Transfer (STTR) funding...
This is a Definitive Contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Engineered Performance Materials Company, LLC, a small business, for a Small Business Innovation Research (SBIR) Phase II project. The contract has a ceiling value of $997,263.00 and a completion date of February 28, 2019. It is a Firm Fixed Price contract, which indicates the contractor will be paid a fixed amount regardless of actual costs incurred. The contract is associated with...
This is a $7,453,975 Cost Plus Fixed Fee definitive contract awarded by the U.S. Air Force to Amsel Medical Corporation, a for-profit medical technology manufacturer based in Cambridge, Massachusetts. The contract is for the non-surgical control of junctional and non-compressible hemorrhage via percutaneously delivered adjustable vessel occlusion. This is a Phase III Small Business Innovation Research (SBIR) Program action, continuing Amsel Medical's work on developing advanced medical...
This is a $1,701,323.05 cost-plus-fixed-fee DARPA SBIR Phase II contract awarded to Optofluidics Inc. (doing business as Halo Labs) for the development of "Point of Injury" sampling technology for battlefield molecular diagnostics. The contract was set aside for small businesses and has an ultimate completion date of September 30, 2015. The contracting agency is the U.S. Army Aviation and Missile Command, which is a defense agency. This SBIR Phase II contract is likely part of...
<p>This is a $207,400.20 firm fixed-price definitive contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Arsenal Medical, Inc. of Waltham, Massachusetts. The contract is for the development of injectable hemostatic prototypes, which are products designed to stop bleeding. The contract does not have a set-aside designation. The award was made on June 23, 2015, with a final completion date of September 21, 2015.</p>
This is a firm fixed-price, SBIR Phase II contract awarded by the Defense Health Agency (DHA) to Nushores Biosciences LLC, a small business. The contract, valued at $1,299,999.94, is for the product development and commercialization readiness of a class of ether-based bioresorbable polyurethanes for biomedical applications. The contract has a period of performance through December 20, 2026. This award is part of the DHA's SBIR program and is designated as a total small business set-aside.
This is a $1,098,542.31 Firm Fixed Price contract awarded by the U.S. Army Combat Capabilities Development Command (CCDC) Soldier Center to Technical Products Inc., a Small Business under the Small Business Innovation Research (SBIR) Program Phase II. The contract was awarded on July 6, 2020 and has an ultimate completion date of October 31, 2023. The contract was awarded under a Broad Agency Announcement (BAA) solicitation that sought white papers and proposals for basic and applied research...
This is a Firm Fixed Price contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Materials Sciences LLC, a small business, for $149,982.42. The contract is for the Small Business Innovation Research (SBIR) Phase I effort entitled "Hybrid Thermoplastic Matrix Fabrication Methods for Missile Support." As an SBIR Phase I award, this contract provides early-stage research funding to develop new composite materials and fabrication methods for...
<p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Desicorp, Inc. for the development of a thermally stable whole blood product for transfusion. The contract has a firm fixed price of $249,957.36 and a completion date of January 17, 2021. As a Phase I SBIR award, this contract is focused on the initial research and feasibility exploration of the proposed technology. The contract was set aside for small businesses.</p>